Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kolb

Showing results (61-70 of 279) with videos related to

Pageof 28
Sort By:
The European Respiratory Journal|May 7, 2026
ERJ Viewpoint: vascular targeted therapies for fibrotic lung disease - Start of a new era?Albina Tyker, Laura C Price, Steven D Nathan, et al.
Respirology (Carlton, Vic.)|July 22, 2010
Have advanced research technologies made real impact on respiratory medicine?Kjetil Ask, Oliver Eickelberg, Jack Gauldie, et al.
The International Journal of Biochemistry & Cell Biology|October 16, 2007
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?Antje Moeller, Kjetil Ask, David Warburton, et al.
Plos One|September 19, 2014
Pulmonary and cardiac function in asymptomatic obese subjects and changes following a structured weight reduction program: a prospective observational studyMatthias Held, Maria Mittnacht, Martin Kolb, et al.
The European Respiratory Journal|December 22, 2022
Reply to: Risk factors for disease progression in fibrotic hypersensitivity pneumonitisM Malik Farooqi, Nathan Hambly, Christopher J Ryerson, et al.
Chest|September 12, 2006
Gene therapy for pulmonary diseasesMartin Kolb, Gail Martin, Maria Medina, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|November 15, 2002
Fatal pericardial tamponade after Wallstent implantation for malignant superior vena cava syndromeMatthias Martin, Iris Baumgartner, Martin Kolb, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 9, 2010
Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosisNarayanan Venkatesan, Mohamed Ouzzine, Martin Kolb, et al.
The European Respiratory Journal|May 28, 2016
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in CanadaRobert B Hopkins, Natasha Burke, Charlene Fell, et al.
American Journal of Physiology. Cell Physiology|May 15, 2023
The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?Elisabeth Fließer, Thomas Lins, Johannes Lorenz Berg, et al.
Pageof 28

Showing results (61-70 of 279) with videos related to

Sort By:
Pageof 28
The European Respiratory Journal|May 7, 2026
ERJ Viewpoint: vascular targeted therapies for fibrotic lung disease - Start of a new era?Albina Tyker, Laura C Price, Steven D Nathan, et al.
Respirology (Carlton, Vic.)|July 22, 2010
Have advanced research technologies made real impact on respiratory medicine?Kjetil Ask, Oliver Eickelberg, Jack Gauldie, et al.
The International Journal of Biochemistry & Cell Biology|October 16, 2007
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?Antje Moeller, Kjetil Ask, David Warburton, et al.
Plos One|September 19, 2014
Pulmonary and cardiac function in asymptomatic obese subjects and changes following a structured weight reduction program: a prospective observational studyMatthias Held, Maria Mittnacht, Martin Kolb, et al.
The European Respiratory Journal|December 22, 2022
Reply to: Risk factors for disease progression in fibrotic hypersensitivity pneumonitisM Malik Farooqi, Nathan Hambly, Christopher J Ryerson, et al.
Chest|September 12, 2006
Gene therapy for pulmonary diseasesMartin Kolb, Gail Martin, Maria Medina, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|November 15, 2002
Fatal pericardial tamponade after Wallstent implantation for malignant superior vena cava syndromeMatthias Martin, Iris Baumgartner, Martin Kolb, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 9, 2010
Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosisNarayanan Venkatesan, Mohamed Ouzzine, Martin Kolb, et al.
The European Respiratory Journal|May 28, 2016
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in CanadaRobert B Hopkins, Natasha Burke, Charlene Fell, et al.
American Journal of Physiology. Cell Physiology|May 15, 2023
The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?Elisabeth Fließer, Thomas Lins, Johannes Lorenz Berg, et al.
Pageof 28